Theodoros Grivas | Medicine and Dentistry | Lifetime Achievement Award

Dr. Theodoros Grivas | Medicine and Dentistry | Lifetime Achievement Award

Tzaneio General Hospital of Piraeus | Greece 

Aurhor Profile

Scopus

Orcid

Google Scholar

🎓 Early Academic Pursuits

Dr. Theodoros B. Grivas began his illustrious journey in medicine by graduating from the Medical School at “Aristotle” University of Thessaloniki in 1978. His academic foundation was further solidified through comprehensive training in General Surgery, Paediatric and Adult Orthopaedics, and Traumatology in Greece. Driven by a passion for deepening his expertise, he pursued and earned a Ph.D. from the National and Kapodistrian University of Athens, establishing a robust foundation for his future contributions to orthopaedic and spinal surgery.

đź’Ľ Professional Endeavors

Throughout his career, Dr. Grivas worked at prestigious institutions, including the “University Hospital” at Queen’s Medical Centre in Nottingham, “Harlow Wood” Orthopaedic Hospital in Mansfield, UK, and prominent hospitals in Athens, Greece. Notably, he served as the Director of the Orthopaedics and Traumatology Department at “Thriasio” Hospital for five years and later at “Tzaneio” General Hospital of Piraeus for 12 years until his retirement in 2021. His leadership and expertise significantly impacted the field, where he played a pivotal role in advancing patient care and surgical practices.

🔬 Contributions and Research Focus

Dr. Grivas has an impressive record of scientific contributions, including over 645 scientific publications and presentations, with 136 indexed in Medline. His research spans various orthopaedic and spinal topics, with a particular focus on school screening programs and spinal deformities. As a principal investigator or collaborator, he was involved in 20 research projects, funded by national and European sources. Additionally, he established a National Training Center for school-screening examiners and was a key figure in implementing the School Screening program in Greece.

🏆 Accolades and Recognition

Dr. Grivas’s achievements have been recognized both nationally and internationally. He has served as a member and Traveling Fellow of renowned organizations like AAOS, AOA, and SRS. He held the presidency of the IRSSD, SOSORT (which he helped found), and the Hellenic Spine Society. His editorial contributions include serving as the Chief Editor of the BMC open access journal “Scoliosis and Spinal Deformities,” and as a member of the editorial board or a reviewer for several peer-reviewed journals. His department was also honored with the opportunity to provide the “Trialect platform” Fellowship in Orthopaedics and Traumatology.

🌍 Impact and Influence

Dr. Grivas’s influence extends beyond his immediate clinical work, impacting the broader medical community through his involvement in critical decision-making bodies. During 2019-2020, he served on the National Examination Committee for Orthopaedics and Traumatology and was a member of the Crisis and Selection Council of the Hellenic National Health System from 2020-2021, which is responsible for the appointment of Orthopaedic Surgeons in State Hospital Positions.

🚀 Legacy and Future Contributions

Even in retirement, Dr. Grivas continues to contribute to the field he has dedicated his life to. He is currently focused on establishing the Hellenic Scoliosis Foundation, aiming to further advance the understanding and treatment of scoliosis. His enduring legacy lies in his vast body of work, the numerous professionals he has mentored, and the patients whose lives he has improved through his expertise in orthopaedics and spinal surgery. His future contributions promise to leave a lasting impact on the field, continuing to inspire and guide the next generation of surgeons.

 

Publications


đź“„ Rib index is a strong surrogate of scoliometric reading in idiopathic scoliosis
Author(s): Grivas, T.B., Jevtic, N., Ljubojevic, D., Mamzari, A., Vasiliadis, E.
Journal: European Spine Journal
Year: 2024


đź“„ Cross-cultural adaptation, reliability and validity of the Greek version of the Spinal Appearance Questionnaire (SAQ) in patients with adolescent idiopathic scoliosis
Author(s): Oikonomaki, M., Kelalis, G., Skouras, A.Z., Georgoudis, G., Grivas, T.
Journal: Spine Deformity
Year: 2024


📄 A Questionnaire of Physiotherapeutic Specific Exercises of Scoliosis—QPSSE
Author(s): Grivas, T.B., Dadakaridou, D., Fokidi, S.A., Theodosopoulos, E., Griva, A.M.
Journal: Journal of Clinical Medicine
Year: 2024


đź“„ Menarche in Scoliotic and Non-Scoliotic Balkan Girls and the Relationship between Menarche and the Laterality of Scoliotic Curves
Author(s): Pjanic, S., Jevtic, N., Grivas, T.B.
Journal: Journal of Clinical Medicine
Year: 2024


đź“„ Segmental Rib Index and Spinal Deformity: Scoliogenic Implications
Author(s): Grivas, T.B., Jevtic, N., Ljubojevic, D., Golic, F., Vasiliadis, E.
Journal: Healthcare (Switzerland)
Year: 2023


 

Christian Pfister | Medicine and Dentistry | Excellence in Research Award

Prof. Christian Pfister | Medicine and Dentistry | Excellence in Research Award

Rouen University Hospital | France

Author Profile

Scopus

Early Academic Pursuits

Prof. Christian Pfister's academic journey commenced with a focus on urology at Charles Nicolle University Hospital in Rouen, France. His early academic pursuits involved comprehensive studies in urological sciences, laying the foundation for a distinguished career in the medical field.

Professional Endeavors

Having established himself as a prominent figure in the field of urology, Prof. Christian Pfister has been associated with the Rouen University Hospital in France. His professional endeavors encompass a wide array of responsibilities within the Department of Urology, where he contributes to patient care, education, and research initiatives.

Contributions and Research Focus

Prof. Pfister's contributions extend beyond clinical practice, with a significant focus on urological research. His research endeavors likely involve advancements in urological treatments, surgical techniques, and potentially groundbreaking discoveries that contribute to the broader medical community's knowledge and understanding.

Accolades and Recognition

Prof. Christian Pfister has likely received accolades and recognition for his outstanding contributions to urology. Recognition may come in the form of awards, honors, or appointments to leadership positions within medical societies, acknowledging his expertise and impact on the field.

Impact and Influence

Prof. Pfister's impact is evident in his influence on the practice of urology, both locally within Rouen University Hospital and potentially on a broader scale. Through his clinical expertise, research contributions, and potential leadership roles, he likely plays a pivotal part in shaping urological practices and advancements.

Legacy and Future Contributions

As a seasoned professional in the field, Prof. Christian Pfister is likely building a lasting legacy in urology. His current contributions, coupled with his dedication to education and patient care, suggest a commitment to leaving a lasting impact on the field. His future contributions may involve mentoring the next generation of urologists and further advancing urological knowledge and treatments.

Notable Publications

Perioperative dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer (VESPER): survival endpoints at 5 years in an open-label, randomised, phase 3 study  2023 (1)

Differential impact of COVID-19 on urological surgeries in public and private institutions between 2019 and 2021 in France | Impact du COVID-19 sur l'activité chirurgicale urologique dans les établissements de santé publics et privés entre 2019 et 2021 en France 2023 (1)

Refining the Characterization and Outcome of Pathological Complete Responders after Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Lessons from the Randomized Phase III VESPER (GETUG-AFU V05) Trial 2023 (4)

Testicular recurrence of oligometastatic prostatic adenocarcinoma after 22 years of androgen deprivation therapy  2022 (1)